Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... through Week 48 The primary study endpoint of ETV-048 was the mean change from baseline HBV DNA at Week 24, analyzed by linear regression and adjusted for baseline...
2009 NOV 16 ... with high oral bioavailability in humans and potent activity against hepatitis B virus (HBV). Woodchucks infected with woodchuck hepatitis virus (WHV) represent an accurate model ...
2009 NOV 16 ... (tenofovir disoproxil fumarate) among adult patients with chronic hepatitis B virus (HBV) infection. These data will be presented at the annual meeting of the American ...
2009 NOV 16 ... According to a study from Nagoya, Japan, "Hepatitis B virus (HBV) of a novel genotype (J) was recovered from an 88-year-old Japanese patient with ...
2009 NOV 23 ... the tissue adjacent to tumor was not changed. In humans in two cases hepatitis B virus (HBV) and in one case hepatitis C virus (HCV) were determined. Investigation showed lack of ...
2009 NOV 16 ... test a previously coined ''charge balance hypothesis'' of human hepatitis B virus (HBV) capsid stability, we established an in vitro disassembly and reassembly system using ...
2009 NOV 23 ... "Entecavir is a potent inhibitor of hepatitis B virus (HBV) polymerase. The efficacy and safety of entecavir in nucleoside-naive patients with ...
2009 NOV 16 ... as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to ...
2009 NOV 16 ... and lymphotropic viral infections after organ transplantation. Hepatitis B virus (HBV) has been identified as a risk factor for non-Hodgkin's lymphoma, but no association ...
2009 NOV 9 ... therapy (ART) is introduced into areas of the world in which hepatitis B virus (HBV) infection is highly endemic, it is important to determine the influence of...
2009 NOV 23 ... the redox status in hepatocellular carcinoma (HCC) induced by hepatitis B virus (HBV), the most important aetiological factor in Taiwan, changes in O-2(center dot) ...
2009 NOV 28 ... and the patients' age. Fifty-eight percent of patients were completely vaccinated for HBV, 85% for OPV, 97% for BCG, 63% for DTP, and 58% of the patients were completely ...
2009 NOV 23 ... carcinogenesis' new findings in hepatitis B virus. "Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are the most important causes of hepatocellular ...
2009 NOV 23 ... According to a study from Taipei, Taiwan, "Hepatitis B virus (HBV) infection is a major cause of hepatocellular carcinoma. This population-based study ...
